Delivery of alprazolam, estazolam, midazolam or triazolam through an inhalation route
CA 2641760 A1 · Owner: Alexza Pharmaceuticals, Inc. · Inventors: Rabinowitz, Joshua D.; Zaffaroni, Alejandro C.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to the delivery of alprazolam estazolam, midazolam or triazolam through an inhalation route. Specifically it relates , to aerosols , containing alprazolam estazolam, midazolam or triazolam that are used in inhalation , therapy. In a composition aspect of the present invention the aerosol , comprises particles , comprising at least (5) percent by weight of alprazolam estazolam, midazolam , or , triazolam. In a method aspect of the present invention alprazolam, estazolam, midlazolam or triazolam is delivered to a mammal through an inhalation route. The , method comprises: a) heating a composition wherein the composition comprises , at least (5) percent by …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 22, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended May 22, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 22, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.